{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:45:10Z","timestamp":1761864310314},"reference-count":20,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJCP"],"published-print":{"date-parts":[[2021,7,9]]},"DOI":"10.5409\/wjcp.v10.i4.48","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T13:09:03Z","timestamp":1625490543000},"page":"48-52","source":"Crossref","is-referenced-by-count":2,"title":["Can omalizumab be used effectively to treat severe conjunctivitis in children with asthma? A case example and review of the literature"],"prefix":"10.5409","volume":"10","author":[{"given":"Stephen","family":"Doherty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"McCrossan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"B1","unstructured":"CEBM.   Oxford Centre for Evidence-Based Medicine: Levels of Evidence 2009. [cited 20 January 2021]. Available from: https:\/\/www.cebm.ox.ac.uk\/resources\/Levels-of-evidence\/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.02.030"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2011.09.011"},{"key":"B4","unstructured":"NICE.   Omalizumab for treating severe persistent allergic asthma, 2013. [cited 2 January 2021]. Available from: www.nice.org.uk\/guidance\/ta278"},{"key":"B5","unstructured":"NICE.   Omalizumab for previously treated chronic spontaneous urticaria, 2015. [cited 2 January 2021]. Available from: www.nice.org.uk\/guidance\/ta339"},{"key":"B6","unstructured":"NICE.   Omalizumab for treating chronic rhinosinusiitis with nasal polyps 2021. [cited 20 January 2021]. Available from: https:\/\/www.nice.org.uk\/guidance\/indevelopment\/gid-ta10558"},{"key":"B7","unstructured":"Genetech USA IaNPC.   XOLAIR [prescribing information]2020 02.02.2021]. [cited 20 January 2021]. Available from: https:\/\/www.xolairhcp.com\/starting-treatment\/dosing.html"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/all.12009"},{"key":"B9","unstructured":"Leonardi A, DeFranchis G, Zancanaro F, Crivellari G, De Paoli M, Plebani M, Secchi AG. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. Invest Ophthalmol Vis Sci 1999; 40: 3036-3040"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(00)00092-0"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s40629-020-00128-4"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2020.01.002"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-016-0074-2"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.5679"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.23.2956"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S223402"},{"key":"B17","unstructured":"Formulary BN.   Omalizuamb: Side effects 2021. [cited 20 January 2021]. Available from: https:\/\/bnf.nice.org.uk\/drug\/omalizumab.html#sideEffects"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2011.08.002"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2012.12.153"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12350"}],"container-title":["World Journal of Clinical Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2219-2808\/full\/v10\/i4\/48.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T13:09:12Z","timestamp":1625490552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2219-2808\/full\/v10\/i4\/48.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":20,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.5409\/wjcp.v10.i4.48","relation":{},"ISSN":["2219-2808"],"issn-type":[{"value":"2219-2808","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,9]]}}}